Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

87.8K
Overview
87.8K
Tissue Transplantation01:24

Tissue Transplantation

1.3K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.3K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

4.6K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant.

Cell reports·2016
Same author

Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis.

BMJ open·2016
Same author

Diversity of the CD4 T Cell Alloresponse: The Short and the Long of It.

Cell reports·2016
Same author

The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2015
Same author

Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.

Kidney international·2014
Same author

Functional characterization of late outgrowth endothelial progenitor cells in patients with end-stage renal failure.

Transplant international : official journal of the European Society for Organ Transplantation·2014

Related Experiment Video

Updated: Apr 13, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.3K

Avoiding immunological rejection in regenerative medicine.

Eleanor M Bolton1, John Andrew Bradley

  • 1Department of Surgery, University of Cambridge, Box 202, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.

Regenerative Medicine
|May 2, 2015
PubMed
Summary
This summary is machine-generated.

Regenerative medicine aims to replace damaged tissues using stem cells. Understanding and overcoming immune rejection is key to the success of these cell replacement therapies.

Keywords:
BelataceptHLA matchingHLA typingimmunosuppressionmixed hematopoietic chimerismstem cell bankingstem cell immunogenicity

More Related Videos

A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
08:33

A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation

Published on: March 20, 2026

43
Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.5K

Related Experiment Videos

Last Updated: Apr 13, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.3K
A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
08:33

A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation

Published on: March 20, 2026

43
Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.5K

Area of Science:

  • Regenerative Medicine
  • Transplantation Immunology

Background:

  • A major goal of regenerative medicine is tissue repair and replacement using stem cells.
  • Immunological rejection of transplanted stem cell-derived tissues is a significant challenge.
  • Overcoming rejection requires understanding immunogenic molecules and rejection pathways.

Purpose of the Study:

  • To review practical strategies for avoiding and overcoming immune rejection in stem cell-derived tissue therapies.
  • To bridge clinical organ transplantation experience with stem cell therapy challenges.
  • To inform the development of safer and more effective cell replacement therapies.

Main Methods:

  • Literature review integrating organ transplantation clinical experience.
  • Analysis of transplantation immunology research findings.
  • Consideration of molecular and mechanistic aspects of immune rejection.

Main Results:

  • Identification of key immunogenic molecules in stem cell therapies.
  • Elucidation of rejection mechanisms relevant to cell replacement.
  • Synthesis of practical approaches based on existing transplantation knowledge.

Conclusions:

  • A deeper understanding of immunogenicity is crucial for successful stem cell therapies.
  • Clinical insights from organ transplantation offer valuable strategies for managing rejection.
  • Developing methods to avoid or overcome immune rejection will advance regenerative medicine.